Conference Coverage

Sepsis response team does not improve mortality/organ dysfunction


 

FROM CHEST 2017

A sepsis response team did not have a positive effect on mortality or organ dysfunction in septic patients, compared with standard treatment by a primary care team, according to a study abstract scheduled to be presented at CHEST 2017.

a scene from an emergency dept., with people rushing and a patient on a stretcher DigitalVision/Thinkstock
The study covers a retrospective analysis of 517 septic patients in an inpatient ward at a tertiary care academic center from June 2014 until December 2016. Of this group, 302 were treated by a sepsis response team, while the others were treated by the normal primary care team.

Compared with the primary care team, the sepsis team was more likely to intervene on patients with a quick Sepsis-Related Organ Failure Assessment score greater than 1 (33.8% vs. 22.8%), change or initiate antibiotics within 3 hours (64.6% vs. 37.2%), and obtain blood cultures on time (66.4% vs 45.2%). An additional difference between the two groups was that the sepsis team had better compliance with the 3-hour bundle (15.2% vs 8.4%).

Despite the sepsis team’s higher level of compliance with certain protocols, the combined outcome measure of mortality and organ dysfunction within 28 days was not significantly higher for patients treated by the sepsis team (11.3% vs. 9.8%; P = .6). In fact, there was at least one downside to being treated by the sepsis team, which was having a 14% longer hospital stay.

Chhaya Patel, MD, is scheduled to present the abstract on Sun., Oct. 29th, at 2:30-2:45 p.m. in Convention Center – 602B. This research is part of the Sepsis & Septic Shock session at the CHEST annual meeting, which will run from 1:30 to 3:00 p.m.

Recommended Reading

Sneak Peek: Journal of Hospital Medicine – Sept. 2017
The Hospitalist
No benefit seen for routine low-dose oxygen after stroke
The Hospitalist
Opioid management protocol lowered trauma patient pain medication use
The Hospitalist
Dabigatran, rivaroxaban linked to slight increase in GI bleeding risk
The Hospitalist
Sneak Peek: Journal of Hospital Medicine – Oct. 2017
The Hospitalist
VA study finds high MRSA infection risk among those colonized with the bacterium
The Hospitalist
Negative nasal swabs reliably predicted no MRSA infection
The Hospitalist
Wait at least 2 days to replace central venous catheters in patients with candidemia
The Hospitalist
Bringing critical care training to hospitalists
The Hospitalist
Ideal intubation position still unknown
The Hospitalist
   Comments ()